Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States; Chevalier Jackson Research Foundation, Esophageal Institute, Western Pennsylvania Hospital, Pittsburgh, PA, United States.
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States.
J Gastrointest Surg. 2024 Nov;28(11):1769-1776. doi: 10.1016/j.gassur.2024.08.007. Epub 2024 Aug 8.
Pyloroplasty is an effective surgery for gastroparesis. However, some patients fail to improve after pyloric drainage and may require subsequent gastric electric stimulation. There is a paucity of data on the efficacy of gastric stimulator as an adjunct to failed pyloroplasty. This study aimed to describe our experience with pyloroplasty, determine the efficacy of gastric stimulator for failed pyloroplasty, and compare the final outcomes of those who required pyloroplasty with and without gastric stimulator for gastroparesis.
Records of patients who underwent primary pyloroplasty for gastroparesis at our institution were reviewed. Patients with poor symptomatic improvement after pyloroplasty underwent subsequent gastric stimulator. Symptoms were assessed using the gastroparesis cardinal symptom index (GCSI) preoperatively and after each surgery. Severe gastroparesis was defined as GCSI total score ≥3. Outcomes were assessed after pyloroplasty in all patients and after stimulator in patients who failed pyloroplasty. Final outcomes were then compared between those who did and did not require adjunct gastric stimulator.
The study population consisted of 104 patients (89.4% females) with a mean (SD) age of 42.2 years (11) and body mass index of 26.9 kg/m (7). Gastroparesis etiologies were 71.2% idiopathic, 17.3% diabetic, and 11.5% postsurgical. At 18.7 months (12) after pyloroplasty, there was a decrease in the GCSI total score (3.5 [1] to 2.7 [1.2]; P = .0012) and the rate of severe gastroparesis (71.9%-29.3%; P < .0001). Gastric emptying scintigraphy (GES) 4-hour retention decreased (36.5 [24] to 15.3 [18]; P = .0003). Adjunct gastric stimulator was required by 30 patients (28.8%) owing to suboptimal outcomes with no improvement in GCSI (P = .201) or GES (P = .320). These patients were younger (40.5 [10.6] vs 49.6 [15.2] years; P = .0016), with higher baseline GCSI total scores (4.3 [0.7] vs 3.7 [1.1]; P < .001) and more severe gastroparesis (100% vs 55.6%; P < .001). All other preoperative characteristics were similar. At 21.7 months (15) after gastric stimulator, there was improvement in GCSI (4.1 [0.7] to 2.6 [1.1]; P < .0001), severe gastroparesis (100%-33.3%; P < .0001), and GES 4-hour retention (21.2 [22] to 7.6 [10]; P = .054). Before gastric stimulator, those who failed pyloroplasty had significantly worse GCSI (P = .0009) and GES (P = .048). However, after gastric stimulator, GCSI and GES improved and were comparable with those who only required pyloroplasty (P > .05).
Pyloroplasty improved gastroparesis symptoms and gastric emptying, yet 28% failed, requiring gastric stimulator. Younger patients and those with preoperative GCSI scores ≥3 were more likely to fail. Gastric stimulator improved outcomes after failed pyloroplasty, with comparable final GCSI and GES with those who did not fail.
幽门成形术是治疗胃轻瘫的有效手术。然而,一些患者在幽门引流后没有改善,可能需要后续进行胃电刺激。关于胃电刺激作为失败的幽门成形术辅助治疗的疗效的数据很少。本研究旨在描述我们在幽门成形术方面的经验,确定胃电刺激对失败的幽门成形术的疗效,并比较因胃轻瘫而行幽门成形术且未行胃电刺激的患者的最终结果。
回顾了我院行原发性幽门成形术治疗胃轻瘫的患者记录。在幽门成形术后症状改善不佳的患者中,随后进行了胃电刺激。术前和每次手术后均使用胃轻瘫卡方症状指数(GCSI)评估症状。严重胃轻瘫定义为 GCSI 总评分≥3。所有患者均在幽门成形术后进行评估,在胃电刺激失败的患者中进行评估。然后比较了需要和不需要辅助胃电刺激的患者的最终结果。
研究人群包括 104 名患者(89.4%为女性),平均年龄为 42.2 岁(11),体重指数为 26.9kg/m²(7)。胃轻瘫的病因分别为 71.2%为特发性、17.3%为糖尿病、11.5%为手术后。在幽门成形术后 18.7 个月(12),GCSI 总评分(3.5[1]至 2.7[1.2];P=0.0012)和严重胃轻瘫的发生率(71.9%-29.3%;P<0.0001)均降低。胃排空闪烁扫描术(GES)4 小时保留率降低(36.5[24]至 15.3[18];P=0.0003)。由于疗效不佳(GCSI 无改善,P=0.201,GES,P=0.320),30 名患者(28.8%)需要辅助胃电刺激。这些患者更年轻(40.5[10.6] vs 49.6[15.2]岁;P=0.0016),基线 GCSI 总评分更高(4.3[0.7] vs 3.7[1.1];P<0.001),胃轻瘫更严重(100% vs 55.6%;P<0.001)。所有其他术前特征均相似。在胃电刺激后 21.7 个月(15),GCSI(4.1[0.7]至 2.6[1.1];P<0.0001)、严重胃轻瘫(100%-33.3%;P<0.0001)和 GES 4 小时保留率(21.2[22]至 7.6[10];P=0.054)均改善。在胃电刺激前,胃电刺激失败的患者 GCSI(P=0.0009)和 GES(P=0.048)明显更差。然而,在胃电刺激后,GCSI 和 GES 得到改善,与仅行幽门成形术的患者相当(P>0.05)。
幽门成形术改善了胃轻瘫症状和胃排空,但 28%的患者失败,需要胃电刺激。年轻患者和术前 GCSI 评分≥3 的患者更有可能失败。胃电刺激改善了失败的幽门成形术的结果,最终的 GCSI 和 GES 与未失败的患者相当。